Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested Capital

Dr Reddys Laboratories (RDY) Equity Ratio (2022 - 2026)

Dr Reddys Laboratories has reported Equity Ratio over the past 5 years, most recently at 0.66 for Q1 2026.

  • For Q1 2026, Equity Ratio fell 3.98% year-over-year to 0.66; the TTM value through Mar 2026 reached 0.66, down 3.98%, while the annual FY2026 figure was 0.66, 1.86% down from the prior year.
  • Equity Ratio for Q1 2026 was 0.66 at Dr Reddys Laboratories, down from 0.68 in the prior quarter.
  • Over five years, Equity Ratio peaked at 22.33 in Q1 2023 and troughed at 0.66 in Q1 2026.
  • A 5-year average of 8.68 and a median of 0.72 in 2024 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: grew 17.55% in 2023 and later tumbled 96.76% in 2024.
  • Year by year, Equity Ratio stood at 19.0 in 2022, then grew by 17.55% to 22.33 in 2023, then tumbled by 96.76% to 0.72 in 2024, then decreased by 5.53% to 0.68 in 2025, then fell by 3.98% to 0.66 in 2026.
  • Business Quant data shows Equity Ratio for RDY at 0.66 in Q1 2026, 0.68 in Q1 2025, and 0.72 in Q1 2024.